| dbo:abbreviation |
Anti-Cancer Drugs |
| dbo:abstract |
Anti-Cancer Drugs ist eine wissenschaftliche Fachzeitschrift, die vom Verlag veröffentlicht wird. Die Zeitschrift erscheint derzeit mit zehn Ausgaben im Jahr. Es werden Arbeiten veröffentlicht, die sich mit therapeutischen gegen Krebs beschäftigen. Der Impact Factor lag im Jahr 2016 bei 2,32. Nach der Statistik des ISI Web of Knowledge wird das Journal mit diesem Impact Factor in der Kategorie Onkologie an 143. Stelle von 217 Zeitschriften und in der Kategorie Pharmakologie und Pharmazie an 162. Stelle von 254 Zeitschriften geführt. (de) Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. The journal has 10 issues per year and the current editor in chief is Mels Sluyser. According to the 2014 Journal Citation Reports, the journal has an impact factor of 1.784, ranking it 164th out of 211 in the category Oncology and 162nd out of 254 in the category Pharmacology & Pharmacy. (en) Anti-Cancer Drugs (ook Anticancer drugs) is een internationaal, aan collegiale toetsing onderworpen wetenschappelijk tijdschrift op het gebied van de oncologie en de farmacologie. Het wordt uitgegeven door Lippincott Williams & Wilkins en verschijnt 10 keer per jaar. (nl) |
| dbo:academicDiscipline |
dbr:Oncology |
| dbo:firstPublicationYear |
1990-01-01 (xsd:gYear) |
| dbo:frequencyOfPublication |
10/year |
| dbo:impactFactor |
1.784000 (xsd:double) |
| dbo:impactFactorAsOf |
2014-01-01 (xsd:gYear) |
| dbo:issn |
0959-4973 1473-5741 |
| dbo:publisher |
dbr:Lippincott_Williams_&_Wilkins |
| dbo:wikiPageExternalLink |
http://journals.lww.com/anti-cancerdrugs/pages/default.aspx |
| dbo:wikiPageID |
26232194 (xsd:integer) |
| dbo:wikiPageLength |
2172 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1068326303 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Journal_Citation_Reports dbc:Oncology_journals dbr:Lippincott_Williams_&_Wilkins dbc:English-language_journals dbc:Lippincott_Williams_&_Wilkins_academic_journals dbc:Publications_established_in_1990 dbr:Chemotherapy dbr:Impact_factor dbr:Oncology dbr:Medical_journal dbr:Editor_in_chief dbr:Anti-cancer_agent |
| dbp:abbreviation |
Anti-Cancer Drugs (en) |
| dbp:discipline |
dbr:Oncology |
| dbp:editor |
Mels Sluyser (en) |
| dbp:eissn |
1473 (xsd:integer) |
| dbp:frequency |
10 (xsd:integer) |
| dbp:history |
1990 (xsd:integer) |
| dbp:impact |
1.784000 (xsd:double) |
| dbp:impactYear |
2014 (xsd:integer) |
| dbp:issn |
959 (xsd:integer) |
| dbp:language |
English (en) |
| dbp:publisher |
dbr:Lippincott_Williams_&_Wilkins |
| dbp:title |
Anti-Cancer Drugs (en) |
| dbp:website |
http://journals.lww.com/anti-cancerdrugs/pages/default.aspx |
| dbp:wikiPageUsesTemplate |
dbt:For dbt:Infobox_journal dbt:Reflist |
| dct:subject |
dbc:Oncology_journals dbc:English-language_journals dbc:Lippincott_Williams_&_Wilkins_academic_journals dbc:Publications_established_in_1990 |
| gold:hypernym |
dbr:Journal |
| rdf:type |
owl:Thing schema:CreativeWork dbo:PeriodicalLiterature dbo:Work wikidata:Q1092563 wikidata:Q234460 wikidata:Q386724 yago:WikicatLippincottWilliams&WilkinsAcademicJournals yago:WikicatOncologyJournals yago:Artifact100021939 yago:Creation103129123 yago:Object100002684 yago:Periodical106593296 yago:PhysicalEntity100001930 yago:Product104007894 yago:Publication106589574 yago:Work104599396 dbo:AcademicJournal dbo:WrittenWork yago:Whole100003553 yago:WikicatEnglish-languageJournals yago:WikicatPublicationsEstablishedIn1990 |
| rdfs:comment |
Anti-Cancer Drugs ist eine wissenschaftliche Fachzeitschrift, die vom Verlag veröffentlicht wird. Die Zeitschrift erscheint derzeit mit zehn Ausgaben im Jahr. Es werden Arbeiten veröffentlicht, die sich mit therapeutischen gegen Krebs beschäftigen. Der Impact Factor lag im Jahr 2016 bei 2,32. Nach der Statistik des ISI Web of Knowledge wird das Journal mit diesem Impact Factor in der Kategorie Onkologie an 143. Stelle von 217 Zeitschriften und in der Kategorie Pharmakologie und Pharmazie an 162. Stelle von 254 Zeitschriften geführt. (de) Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents. It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. The journal has 10 issues per year and the current editor in chief is Mels Sluyser. According to the 2014 Journal Citation Reports, the journal has an impact factor of 1.784, ranking it 164th out of 211 in the category Oncology and 162nd out of 254 in the category Pharmacology & Pharmacy. (en) Anti-Cancer Drugs (ook Anticancer drugs) is een internationaal, aan collegiale toetsing onderworpen wetenschappelijk tijdschrift op het gebied van de oncologie en de farmacologie. Het wordt uitgegeven door Lippincott Williams & Wilkins en verschijnt 10 keer per jaar. (nl) |
| rdfs:label |
Anti-Cancer Drugs (en) Anti-Cancer Drugs (de) Anti-Cancer Drugs (nl) |
| owl:sameAs |
freebase:Anti-Cancer Drugs yago-res:Anti-Cancer Drugs wikidata:Anti-Cancer Drugs dbpedia-de:Anti-Cancer Drugs dbpedia-nl:Anti-Cancer Drugs https://global.dbpedia.org/id/4RF4p |
| prov:wasDerivedFrom |
wikipedia-en:Anti-Cancer_Drugs?oldid=1068326303&ns=0 |
| foaf:homepage |
http://journals.lww.com/anti-cancerdrugs/pages/default.aspx |
| foaf:isPrimaryTopicOf |
wikipedia-en:Anti-Cancer_Drugs |
| foaf:name |
Anti-Cancer Drugs (en) |
| is dbo:wikiPageRedirects of |
dbr:Anti-Cancer_Drugs_(journal) dbr:Anticancer_Drugs |
| is dbo:wikiPageWikiLink of |
dbr:Anti-Cancer_Drugs_(journal) dbr:Barkat_Pharmaceutical_Group dbr:Anticancer_Drugs |
| is foaf:primaryTopic of |
wikipedia-en:Anti-Cancer_Drugs |